| 期 |
栏目 |
标题 |
文件 |
| 卷 160, 编号 4 (2016) |
Microbiology and Immunology |
Role of Hematopoietic Stem Cells in Inflammation of the Pancreas during Diabetes Mellitus |
|
| 卷 161, 编号 5 (2016) |
Article |
Effect of Granulocyte Colony-Stimulating Factor Immobilized by the Electron-Beam Synthesis Nanotechnology on Reparative Regeneration of Spermatogenous Tissue |
|
| 卷 162, 编号 3 (2017) |
Morphology and Pathomorphology |
Regenerative Potential of Stem and Progenitor Cells from Ischemic Testes of C57Bl/6 Mice in Culture and in the Model of Spermatogenesis Suppression Caused by Busulfan |
|
| 卷 163, 编号 2 (2017) |
Article |
Regenerative Potential of Spermatogonial Stem Cells, Endothelial Progenitor Cells, and Epithelial Progenitor Cells of C57Bl/6 Male Mice with Metabolic Disorders |
|
| 卷 163, 编号 4 (2017) |
Oncology |
Assessment of Erythroid and Granulocytic Hematopoietic Lineages in Patients with Non-Small-Cell Lung Carcinoma |
|
| 卷 164, 编号 2 (2017) |
General Pathology and Pathophysiology |
Role of Sertoli and Leydig Cells in the Regulation of Spermatogonial Stem Cell and Development of Reproductive Disorders in Male C57Bl/6 Mice with Type 1 Diabetes Mellitus |
|
| 卷 164, 编号 5 (2018) |
Article |
Experimental Analysis of the Efficacy of Dihydroquercetin on the Model of Chronic Nonbacterial Inflammation of the Prostatic Gland |
|
| 卷 166, 编号 1 (2018) |
General Pathology and Pathophysiology |
Experimental Study of the Effectiveness of Phenolic Antioxidants in Male Infertility Caused by Pathospermia |
|
| 卷 166, 编号 1 (2018) |
Oncology |
Mechanisms of Granulocytopoiesis Recovery Stimulation with Filgrastim in Breast Cancer Patients Receiving Chemotherapy |
|
| 卷 166, 编号 2 (2018) |
Article |
Endothelial Progenitor Cells and Notch-1 Signaling as Markers of Alveolar Endothelium Regeneration in Pulmonary Emphysema |
|
| 卷 167, 编号 5 (2019) |
General Pathology and Pathological Physiology |
Effectiveness of Phenolic Antioxidants in Experimental Model of Benign Prostatic Hyperplasia |
|
| 卷 168, 编号 2 (2019) |
Oncology |
Responses of Blood System to Doxorubicin/Docetaxel Chemotherapy in Patients with Breast Cancer |
|
